in Genetics and Biochemistry from University of Wisconsin-Madison.ĭorottya Nagy-Szakal, MD PhD Chief Medical Officer of biotiaĭr. in Genetics from Yale University, and his dual B.S. Mason completed his dual post-doctoral training at Yale Medical School in genetics and a fellowship at Yale Law School. His work represents 150+ peer-reviewed articles and has been featured on the covers of Nature, Science or Nature Biotechnology.ĭr. He was named as one of the “Brilliant Ten” Scientists by Popular Science, and featured as a TEDMED speaker. Mason has won awards from the NIH, the CDC and the WorldQuant Foundation. These methods are also being integrated for longitudinal multi-omic profiling of NASA astronauts and for genetic and epigenetic diagnostics on the International Space Station.ĭr. The group also works closely with NIST/FDA to build international standards. The Mason lab develops and deploys new biochemical and computational methods in functional genomics, and metagenomics. She was selected as a TedMed Hive Innovator for 2020.Ĭhristopher Mason, PhD Co-founder of Biotia and Associate Professor at Weill Cornell Medicine Her work has been featured in GenomeWeb, Popular Science, the Huffington Post, and WIRED. O'Hara has published peer-reviewed articles in the fields of metagenomics, genomics, evolutionary biology and ecology in top ranked journals such as Molecular Ecology, Microbiome, and Evolution. She is a research assistant professor at SUNY Downstate Health Sciences University, completed a postdoc in health tech business at Cornell Tech (2018), a postdoc at Fordham University in Bioinformatics (2015), a PhD in Ecology and Evolutionary Biology at Stony Brook University (2014), and a bachelor’s at NYU (2005).ĭr. She has led unprecedented, large-scale metagenomics and NGS work characterizing the microbiome of ambulances across the US, hospital environments, the urine microbiome, and SARS-CoV-2 samples. O'Hara has developed cutting edge next-gen sequencing-based technology for hospitals and spent five years commercializing this technology. Niamh O’Hara, PhD Co-founder and CEO of biotiaĭr.
0 kommentar(er)
